In-patient versus out-patient withdrawal programmes for medication overuse headache: A 2-year randomized trial

被引:27
作者
Creac'h, C. [1 ]
Frappe, P. [2 ]
Cancade, M. [1 ]
Laurent, B. [1 ]
Peyron, R. [1 ]
Demarquay, G. [3 ]
Navez, M. [1 ]
机构
[1] N Univ Hosp, Paris, France
[2] UJM St Etienne Univ, St Etienne, France
[3] Croix Rousse Hosp, Lyon, France
关键词
Chronic daily headache; migraine; in-patient withdrawal; out-patient withdrawal; medication overuse headache; dependency; OPEN-LABEL TRIAL; FOLLOW-UP; CLINICAL-FEATURES; ANALGESIC OVERUSE; MIGRAINE PATIENTS; TRANSFORMED MIGRAINE; DEPENDENCE; THERAPY; PREDICTORS; DRUGS;
D O I
10.1177/0333102411412088
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Medication-overuse headache (MOH) management usually includes a medication withdrawal. The choice of withdrawal modalities remains a matter of debate. Methods: We compared the efficacy of in-patient versus out-patient withdrawal programmes in 82 consecutive patients with MOH in an open-label prospective randomized trial. The main outcome measure was the reduction in number of headache days after 2 months and after 2 years. The responders were defined as patients who had reverted to episodic headaches and to an intake of acute treatments for headache less than 10 days per month. Results: Seventy-one patients had a complete drug withdrawal (n = 36 in the out-patient group; n = 35 in the in-patient group). The reduction of headache frequency and subjective improvement did not differ between groups. The long-term responder rate was similar in the out-and in-patient groups (44% and 44%; p = 0.810). The only predictive factor of a bad outcome 2 years after withdrawal was an initial consumption of more than 150 units of acute treatments for headache per month (OR 3.1; 95% confidence interval 1.1-9.3; p = 0.044). Conclusion: Given that we did not observe any difference in efficacy between the in-and out-patient withdrawals, we would recommend out-patient withdrawal in the first instance for patients with uncomplicated MOH.
引用
收藏
页码:1189 / 1198
页数:10
相关论文
共 55 条
[1]  
*ANAES, CEPH CHRON QUOT DIAG
[2]  
*ANAES, PRIS CHARG DIAGN THE
[3]   Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP [J].
Boe, M. G. ;
Salvesen, R. ;
Mygland, A. .
CEPHALALGIA, 2009, 29 (08) :855-863
[4]   Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy [J].
Boe, M. G. ;
Salvesen, R. ;
Mygland, A. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (06) :705-712
[5]   Epidemiology of chronic daily headache in the general population [J].
Castillo, J ;
Muñoz, P ;
Guitera, V ;
Pascual, J .
HEADACHE, 1999, 39 (03) :190-196
[6]   Chronic daily headache with analgesic overuse -: Epidemiology and impact on quality of life [J].
Colás, R ;
Muñoz, P ;
Temprano, R ;
Gómez, C ;
Pascual, J .
NEUROLOGY, 2004, 62 (08) :1338-1342
[7]   One or Several Types of Triptan Overuse Headaches? [J].
Creac'h, Christelle ;
Radat, Francoise ;
Mick, Gerard ;
Guegan-Massardier, Evelyne ;
Giraud, Pierric ;
Guy, Nathalie ;
Fabre, Nelly ;
Nachit-Ouinekh, Fatima ;
Lanteri-Minet, Michel .
HEADACHE, 2009, 49 (04) :519-528
[8]   Medication overuse headache: Neurobiological, behavioural and therapeutic aspects [J].
Cupini, Letizia M. ;
Sarchielli, Paola ;
Calabresi, Paolo .
PAIN, 2010, 150 (02) :222-224
[9]   Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse [J].
Diener, H-C ;
Dodickz, D. W. ;
Goadsby, P. J. ;
Bigal, M. E. ;
Bussone, G. ;
Silberstein, S. D. ;
Mathew, N. ;
Ascher, S. ;
Morein, J. ;
Hulihan, J. F. ;
Biondi, D. M. ;
Greenberg, S. J. .
CEPHALALGIA, 2009, 29 (10) :1021-1027
[10]   ANALGESIC-INDUCED CHRONIC HEADACHE - LONG-TERM RESULTS OF WITHDRAWAL THERAPY [J].
DIENER, HC ;
DICHGANS, J ;
SCHOLZ, E ;
GEISELHART, S ;
GERBER, WD ;
BILLE, A .
JOURNAL OF NEUROLOGY, 1989, 236 (01) :9-14